CENTURY(SZ:300078) Xin Jing Bao·2025-05-30 12:59Core Viewpoint - The company intends to divest its wholly-owned subsidiary, Yihui Technology, due to ongoing losses impacting overall performance and negative factors affecting its reputation, with the stake being acquired by Cangnan State-owned enterprise, Shanhai Data Technology [2][4][5]. Group 1: Financial Performance - The parent company, Sichuang Yihui, has faced continuous losses since 2021, with net profits of -685 million yuan, -878 million yuan, -874 million yuan, and -502 million yuan projected from 2021 to 2024 [3]. - Yihui Technology, the core of the smart medical segment, reported a revenue of 169 million yuan in 2024, down significantly from 417 million yuan in 2022, with a net profit of -320 million yuan [3][4]. - The smart medical business has been severely impacted by market competition and administrative penalties, leading to substantial operational losses [4]. Group 2: Administrative Issues - The company faced administrative penalties due to a fraudulent issuance incident, resulting in a fine of 85.7 million yuan and a 10-year market ban for the former chairman [4][5]. - The negative reputation from these penalties has hindered Yihui Technology's ability to secure contracts with major public hospitals, affecting its business development [4]. Group 3: Strategic Shift - The divestiture of Yihui Technology is expected to improve the company's financial situation, with the estimated valuation of the subsidiary at approximately 300 million yuan [5]. - Following the sale, the company will focus on its commercial intelligence business, which has shown a revenue decline of 15.01% in 2024, generating 501 million yuan [7][8]. - The commercial intelligence segment is a significant player in the EAS market and aims to leverage its position to recover from current challenges [8].